HF
CTSO icon

HRT Financial’s Cytosorbents Corp CTSO Stock Holding History

HRT Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Buy
32,125
+18,012
+128% +$9.51K ﹤0.01% 3971
2026
Q1 		$7K Buy
+14,113
New +$9.63K ﹤0.01% 3653
2025
Q1 		– Sell
-11,509
Closed -$10K – 2651
2024
Q4 		$10K Buy
+11,509
New +$11.3K ﹤0.01% 2281
2023
Q4 		– Sell
-10,256
Closed -$19K – 2427
2023
Q3 		$19K Buy
+10,256
New +$29.4K ﹤0.01% 2076
2021
Q3 		– Sell
-15,560
Closed -$117K – 3366
2021
Q2 		$117K Buy
+15,560
New +$131K ﹤0.01% 2556
2021
Q1 		– Sell
-15,262
Closed -$121K – 2757
2020
Q4 		$121K Buy
+15,262
New +$128K ﹤0.01% 1606

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial's CTSO Position: Q2 2026 in Review

HRT Financial increased its Cytosorbents Corp (CTSO) stake by 128% in Q2 2026, buying an estimated $9.51K and bringing the position to 32,125 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3971.

HRT Financial first reported a position in CTSO in Q4 2020 and has held it in 6 quarters since. The position peaked at $121K in Q4 2020. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • HRT Financial held 32,125 shares of Cytosorbents Corp worth $12K as of Q2 2026.
  • HRT Financial bought 18,012 Cytosorbents Corp shares in Q2 2026, an estimated $9.51K.
  • Cytosorbents Corp made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3971 holding.
  • HRT Financial first reported a position in Cytosorbents Corp in Q4 2020 and has held it in 6 quarters since.
  • HRT Financial's Cytosorbents Corp position peaked at $121K in Q4 2020.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.